Pola-R-CHP - Polatuzumab Vedotin 1.8 / Rituximab 375 / Cyclophosphamide 750 / Doxorubicin 50 / Prednisolone 100, diffuse large B-non-Hodgkin Lymphoma, cycle 1-6 (PID1920 V1.0)
Cyclophosphamide (ATC L01AA01)
- PC Compound: Cyclophosphamide
- PC Substance: Cyclophospamid
Dimetinden (ATC R06AB03)
- PC Compound: Dimetinden
- PC Substance: Dimetinden
- PC Substance: Dimetindenmaleat
Doxorubicin (ATC L01DB01)
- PC Compound: Doxorubicin
- PC Substance: DoxorubicinHCl
Granisetron (ATC A04AA02)
- EMA EPAR: Granisetron (Sancuso, 3.1 mg/24 hours transdermal
- EMA URL: Kytril, granisetron
- PC Compound: Granisetron
- PC Substance: Granisetron
Mesna (ATC V03AF01)
- PC Compound: Mesna
- PC Substance: Mesna
- URL: Mesna WHO 2009
Paracetamol (ATC N02BE01)
- PC Compound: Paracetamol
Pegfilgrastim (ATC L03AA13)
- EMA EPAR: Pegfilgrastim (neulasta)
- PC Substance: Pegfilgrastim
- PC Substance: Pegfilgrastim
Polatuzumab vedotin (ATC L01FX14)
- EMA EPAR: Polatuzumab vedotin (polivy)
- PC Substance: Polatuzumab vedotin
Prednisolone (ATC H02AB06)
- PC Compound: Prednisolone